Stock Code 300119
Stock Price 0.00
0.00%
产品家族
Product & Services
Current Location:
Product & Service>
Products

Reset
×
Ceforolin (DC)
Medicine

Product Features

1. Broad Spectrum of Drug Efficacy

This product has good antibacterial activity against common pathogens of dairy cow mastitis, and strong antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. With significant effect on streptococcus, staphylococcus aureus, Escherichia coli, corynebacterium and so on, it can effectively get cows through the dry period safely.

2. Slow Release, Long Action and Efficient Penetration

The product adopts encapsulation and slow-release technology, and the minimum effective inhibitory concentration can last for more than 7 weeks. At the same time, the particle fineness of the active ingredient of the product reaches the nanoparticle fineness, which is easy to spread, penetrate and directly target the lesion in the breast, and thus provide good protection against mastitis.

3. Safe to Use and Little Irritation

The product has slight side effects, low toxicity and no chronic toxicity. There is no swelling in the milk area and no irritation in cows after use.

4. A Short Withdrawal Period

The short withdrawal period ensures the safety of the cow's postpartum milk, and the milk withdrawal period is 24 hours.

5. Good Product Stability

High temperature and low temperature resistance, stable properties, quality assurance.

6. New drenching Device, Good Animal Welfare, and Easy to Use

The injection needle is thinner and more flexible, and the cow has no discomfort. 

Figure 1: The Bacteriological Treatment Rate of Ceforolin (DC) Products Performing Well in the Field When Used in the Dry Period

image.png 


Table 1 The Change of Main Pathogenic Bacteria Infection Rates in the Milk Area of Dairy Cows Using Ceforolin (DC) Products during the Dry Period and Different Periods after Calving

image.png

Notes: Streptococcus mainly consists of Streptococcus agalactiae, Streptococcus agalactiae, Streptococcus mammary and Streptococcus bovis. Streptococcus agalactis is the dominant bacterium. Staphylococcus mainly consists of coagulase positive and coagulase negative staphylococcus, and coagulase negative staphylococcus is the dominant bacterium.

The test verifies that the bacteriological cure rate of Escherichia coli, staphylococcus and streptococcus were 80%, 84.4% and 100% 3 days after calving when each milk area was injected with one bottle of Ceforolin (DC) during the dry period. The somatic cell count in the milk decreased from 913,000 cfu/mL during the dry period to 201,000 cfu/mL on day 3 after calving and 202,000 cfu/mL on day 5 after calving. In conclusion, the cure rate of Ceforolin (DC) on clinical mastitis in the dry period of dairy cows is greater than 80%, and the somatic cell count in the dry period of dairy cows is reduced by 80%, reflecting the good clinical effect and bactericidal rate of the product.

Usage and Dosage

Use a short nipple tube for drenching of one bottle of the product in each milk area of the dairy cows during the dry period.

Directions

After the cow is milked, wipe the nipple holes with alcohol test strips and perfuse one bottle of the product into each milk area.

 

Packing Specifications: 3g: 150 mg/Bottle, 45 Bottles/Box x 4 Boxes/Carton



×
Copyright 2023 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD. All rights reserved